Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daneman

Showing results (841-850 of 849) with videos related to

Pageof 85
Sort By:
You have reached the last page of results.This site can display upto 849 results.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 26, 2024
Effects of Losartan on Patients Hospitalized for Acute COVID-19: A Randomized Controlled TrialKaren C Tran, Pierre Asfar, Matthew Cheng, et al.
CMAJ Open|March 10, 2021
Characteristics and outcomes of patients with COVID-19 admitted to hospital and intensive care in the first phase of the pandemic in Canada: a national cohort studySrinivas Murthy, Patrick M Archambault, Anika Atique, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 27, 2020
Association Between Minimum Inhibitory Concentration, Beta-lactamase Genes and Mortality for Patients Treated With Piperacillin/Tazobactam or Meropenem From the MERINO StudyA Henderson, D L Paterson, M D Chatfield, et al.
Critical Care Medicine|July 1, 2016
Influenza A (H1N1pdm09)-Related Critical Illness and Mortality in Mexico and Canada, 2014Guillermo Dominguez-Cherit, Alethse De la Torre, Asgar Rishu, et al.
Nature Communications|August 19, 2023
CD98hc is a target for brain delivery of biotherapeuticsKylie S Chew, Robert C Wells, Arash Moshkforoush, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|January 20, 2022
Remdesivir for the treatment of patients in hospital with COVID-19 in Canada: a randomized controlled trialKarim Ali, Tanweer Azher, Mahin Baqi, et al.
The New England Journal of Medicine|November 20, 2024
Antibiotic Treatment for 7 versus 14 Days in Patients with Bloodstream Infections, Nick Daneman, Asgar Rishu, et al.
The New England Journal of Medicine|June 17, 2026
Cefazolin for Methicillin-Susceptible <i>Staphylococcus aureus</i> Bacteremia, Todd C Lee, Lauren A Barina, et al.
JAMA|September 3, 2020
Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19: The REMAP-CAP COVID-19 Corticosteroid Domain Randomized Clinical TrialDerek C Angus, Lennie Derde, Farah Al-Beidh, et al.
Pageof 85

Showing results (841-850 of 849) with videos related to

Sort By:
Pageof 85
You have reached the last page of results.This site can display upto 849 results.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 26, 2024
Effects of Losartan on Patients Hospitalized for Acute COVID-19: A Randomized Controlled TrialKaren C Tran, Pierre Asfar, Matthew Cheng, et al.
CMAJ Open|March 10, 2021
Characteristics and outcomes of patients with COVID-19 admitted to hospital and intensive care in the first phase of the pandemic in Canada: a national cohort studySrinivas Murthy, Patrick M Archambault, Anika Atique, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 27, 2020
Association Between Minimum Inhibitory Concentration, Beta-lactamase Genes and Mortality for Patients Treated With Piperacillin/Tazobactam or Meropenem From the MERINO StudyA Henderson, D L Paterson, M D Chatfield, et al.
Critical Care Medicine|July 1, 2016
Influenza A (H1N1pdm09)-Related Critical Illness and Mortality in Mexico and Canada, 2014Guillermo Dominguez-Cherit, Alethse De la Torre, Asgar Rishu, et al.
Nature Communications|August 19, 2023
CD98hc is a target for brain delivery of biotherapeuticsKylie S Chew, Robert C Wells, Arash Moshkforoush, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|January 20, 2022
Remdesivir for the treatment of patients in hospital with COVID-19 in Canada: a randomized controlled trialKarim Ali, Tanweer Azher, Mahin Baqi, et al.
The New England Journal of Medicine|November 20, 2024
Antibiotic Treatment for 7 versus 14 Days in Patients with Bloodstream Infections, Nick Daneman, Asgar Rishu, et al.
The New England Journal of Medicine|June 17, 2026
Cefazolin for Methicillin-Susceptible <i>Staphylococcus aureus</i> Bacteremia, Todd C Lee, Lauren A Barina, et al.
JAMA|September 3, 2020
Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19: The REMAP-CAP COVID-19 Corticosteroid Domain Randomized Clinical TrialDerek C Angus, Lennie Derde, Farah Al-Beidh, et al.
Pageof 85